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MaOBJECTIVES The goal of this study was to compare the diagnostic accuracy of the coronary artery calcium score
(CACS), coronary computed tomography angiography (CTA), single-photon emission computed tomography (SPECT), and
a combination of these tools in the diagnosis of obstructive coronary artery disease (CAD) in patients with chronic kidney
disease referred for cardiac evaluation before kidney transplantation.
BACKGROUND The optimal method for the detection of obstructive CAD in potential kidney transplant patients has
not yet been identiﬁed. Previous studies have found that established noninvasive stress tests have low diagnostic
accuracy, while the diagnostic performance of coronary CTA remains unknown.
METHODS We prospectively studied 138 patients referred for pre-transplant cardiac evaluation (mean age 54 years; age
range 22 to 72 years; 68% male; 43% treated with dialysis). All patients underwent CACS, coronary CTA, SPECT, and
invasive coronary angiography. The results of the noninvasive tests were merged into integrated hybrid imaging results:
Hybrid (CACS/SPECT) and Hybrid (coronary CTA/SPECT).
RESULTS The overall prevalence of obstructive CAD ($50% reduction in luminal diameter) according to quantitative
invasive coronary angiography was 22%. Two-thirds of the patients with obstructive CAD had a stenosis located in
a proximal coronary segment. In a patient-level model, the sensitivity and speciﬁcity, respectively, for diagnosing
obstructive CAD were as follows: CACS (threshold of 400), 67% and 77%; coronary CTA, 93% and 63%; SPECT, 53%
and 82%; Hybrid (CACS/SPECT), 33% and 97%; and Hybrid (coronary CTA/SPECT), 67% and 86%. The sensitivity for
diagnosing obstructive CAD in a proximal segment was 70% for CACS (threshold 400), 100% for coronary CTA, 60% for
SPECT, 40% for Hybrid (CACS/SPECT), and 75% for Hybrid (coronary CTA/SPECT).
CONCLUSIONS Coronary CTA is a reliable test with high sensitivity and a high negative predictive value for diagnosing
obstructive CAD before kidney transplantation. A noninvasive approach with use of either coronary CTA or a combination
of coronary CTA and SPECT to rule out obstructive CAD seems recommendable in kidney transplant candidates.
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ABBR EV I A T I ON S
AND ACRONYMS
CACS = coronary artery
calcium score
CAD = coronary artery disease
CI = conﬁdence interval
CKD = chronic kidney disease
CKD-5 = stage 5 chronic
kidney disease
CTA = computed tomography
angiography
ICA = invasive coronary
angiography
NLR = negative likelihood ratio
NPV = negative predictive
value
PLR = positive likelihood ratio
PPV = positive predictive value
SPECT = single-photon
emission computed
tomography
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554P atients with chronic kidney disease(CKD) have a high risk of cardiovascu-lar events. In addition, symptoms of
coronary artery disease (CAD) may be atyp-
ical due to neuropathy, overhydration, or
low functional capacity. After kidney trans-
plantation, cardiovascular risk is reduced
but remains the most signiﬁcant cause of
morbidity and mortality (1,2). No prospective
study has yet demonstrated the beneﬁt of
cardiac risk stratiﬁcation before kidney trans-
plantation. Optimizing medical treatment,
pre-operative coronary revascularization,
and individualized perioperative manage-
ment might reduce the event rate after trans-
plantation. Consequently, most institutions
evaluate pre-operative cardiac state in accor-
dance with the American Heart Association
and the American College of Cardiology
Foundation scientiﬁc statement (“Cardiac
Disease Evaluation and Management AmongKidney and Liver Transplantation Candidates–2012”)
(2). This statement recommends that “noninvasive
cardiac stress testing may be considered in kidney
transplantation candidates with no active cardiac
conditions on the basis of the presence of multiple
CAD risk factors regardless of functional status” (2).SEE PAGE 563However, the diagnostic accuracy of noninvasive
cardiac stress testing, such as single-photon emission
computed tomography (SPECT), varies in patients
with severe CKD (i.e., stage 5 [CKD-5]). A recent
Cochrane review concluded that the pooled sensi-
tivity of SPECT was 0.67 (95% conﬁdence interval
[CI]: 0.48 to 0.82), with a speciﬁcity of 0.77 (95% CI:
0.61 to 0.88), in kidney transplant candidates (3).
Because the diagnostic accuracy of noninvasive stress
testing is low, invasive coronary angiography (ICA)
remains the gold standard for diagnosing obstruc-
tive CAD in kidney transplant candidates. ICA con-
tinues to be the preferred diagnostic tool in many
institutions (4) despite the fact that the risk of com-
plications is increased in patients with CKD.
The coronary artery calcium score (CACS), as
assessed by using nonenhanced computed tomogra-
phy, provides an absolute measure of coronary
calciﬁcation, adds prognostic information, and cor-
relates moderately with obstructive CAD (5,6). Coro-
nary computed tomography angiography (CTA) is
established as a noninvasive diagnostic test for ste-
nosis in patients without CKD. Coronary CTA has
been shown in several multicenter studies to have a
high sensitivity (5,7). However, its speciﬁcity is notoptimal due to false-positive results in patients with
extensive coronary calciﬁcations or high/irregular
heart rates. These factors could be prevalent in kid-
ney transplant candidates and affect the applicability
of coronary CTA in this patient group. To our
knowledge, no prospective studies have investigated
the diagnostic accuracy of coronary CTA in patients
with advanced CKD.
The combination of an anatomic test of stenosis
(e.g., CACS or coronary CTA) and a functional stress
evaluation of myocardial ischemia (e.g., SPECT) is
known as cardiac hybrid imaging. This imaging
has demonstrated improved sensitivity and speci-
ﬁcity in patients with a high risk of CAD (8). It is
unknown whether this would also apply in patients
with CKD.
The aim of the present study was to compare the
accuracy of diagnosing obstructive CAD by using
CACS, coronary CTA, SPECT, and a combination of
these techniques (with ICA as the reference) in a large
cohort of kidney transplantation candidates.
METHODS
STUDY DESIGN. We conducted a prospective, obser-
vational, single-arm study enrolling patients with
CKD referred for cardiac evaluation before kidney
transplantation. Patients were recruited consecu-
tively from 9 hospitals in the western part of Denmark
from February 2011 to February 2014. Inclusion
criteria were CKD and presence of at least 1 of the
following characteristics: age >40 years, diabetes,
dialysis treatment for >5 years, registered on kidney
transplant waiting list for >3 years without cardiac
screening, symptoms of cardiovascular disease, and
the ability to provide informed written consent.
Exclusion criteria were age <18 years and unstable
angina pectoris. Written informed consent was ob-
tained from all patients. The study was approved by
the Danish Data Protection Agency and the Central
Denmark Region Committees on Health Research
Ethics, and it followed the principles in the Declara-
tion of Helsinki.
All patients were scheduled for the following:
1) CACS and coronary CTA; 2) stress SPECT; and 3)
ICA. When clinically required, a rest SPECT was
performed (Figure 1). All diagnostic tests were
performed at Aarhus University Hospital, Aarhus,
Denmark. After study completion, patients were fol-
lowed up for 30 days to register any complications,
including acute kidney failure.
To prevent contrast-induced nephropathy, patients
received oral acetylcysteine (600 mg) the day before
and on the day of both the coronary CTA and the
FIGURE 1 Patient Flow Chart
Single-photon emission computed tomography (SPECT)
Coronary artery calcium score (CACS) and
coronary computed tomography angiography (CTA)
Invasive coronary angiography (ICA)
Final study cohort: N = 138 
Included in the study: n = 167
Excluded before diagnostic tests (n = 13) due to:
• Withdrawal of consent (n = 5)
• Hospitalization for acute myocardial infarction (n = 4)
• Previous coronary artery bypass grafting (n = 3)
• Renal transplantation performed (n = 1)
ICA not performed (n = 6) due to:
• Fatal endocarditis (n = 1)
• Renal transplantation not possible (n = 3)
• Intra-arterial access not possible (n = 1)
• Improved renal function (n = 1)
Coronary CTA not performed (n = 7) due to:
• Previous allergic reaction to contrast media (n = 2)
• Intra-venous access not possible (n = 4)
• Patient refused coronary CTA (n = 1) 
SPECT not performed (n = 3) due to:
• Severe side effect to adenosine (n = 2)
• Chronic obstructive pulmonary disease and
   beta-blocker treatment (n = 1)
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555ICA. In addition, the procedures with contrast media
exposure were performed at least 4 weeks apart in all
patients with CKD-5 and in those with CKD-5 under-
going dialysis who had preserved urine production.
Analysis of the diagnostic test results was per-
formed on a patient-level basis. Proximal coronary
segments were deﬁned as left main coronary artery,
proximal and middle segment of the left anterior
descending artery, and proximal segment of the left
circumﬂex artery and right coronary artery until the
crux. Analyses of the diagnostic test results were
performed by 2 experienced cardiologists or 2 nuclear
medicine physicians. In case of disagreement be-
tween the 2 readers, a consensus decision was ob-
tained. All readers were blinded to the results of the
other diagnostic tests.
CACS AND CORONARY CTA ACQUISITION AND
INTERPRETATION. Computed tomography scans
were performed on a dual-source scanner (SOMATOM
Deﬁnition Flash, Siemens Healthcare, Erlangen,
Germany). A nonenhanced scan was performed to
access the Agatston CACS. Pre-speciﬁed CACS
thresholds of 0 and 400 were used to analyze accu-
racy. Contrast-enhanced coronary CTA was acquired
with prospective electrocardiogram gating. A spiral
acquisition protocol (0% to 100% of the heart cycle)was applied in all patients, with dose modulation in
the systolic or diastolic phase depending on heart
rate. Tube settings were dependent on patient
weight, and current modulation was applied. Coro-
nary images were reconstructed for every 5%
of the cardiac cycle by using raw data iterative
reconstruction. In relation to the cardiac scan, a
high-pitch, low-dose ﬂash scan was performed for
evaluation of the aorta and iliac arteries using the
same contrast injection. The contrast medium used
was ioversol (350 mg/ml), and all patients received
glyceryl nitrate (0.8 mg) sublingually before the
CTTA. In addition, intravenous metoprolol was
administered to obtain a heart rate of <65 beats/min
to optimize coronary CTA images.
All coronary segments were visually analyzed ac-
cording to standard clinical practice with the use of
commercially available software (syngo.via, Siemens
Healthcare) (5,6). The coronary CTA readers were
permitted to use all the available post-processing
image reconstruction algorithms, including axial im-
ages, multiplanar and curved reformation, maximal
intensity projection, volume-rendered technique, and
cross-sectional area analysis. A semi-quantitative
scale was used to grade the extent of luminal diam-
eter stenosis. The stenosis severity was obtained in
FIGURE 2 Hybrid Imaging
A
SPECT
lamronbAlamroN
< 400
≥ 400
CACS
Hybrid (CACS/SPECT):
Normal
Hybrid (CACS/SPECT):
Normal
Hybrid (CACS/SPECT):
Normal
Hybrid (CACS/SPECT): 
Abnormal
B
SPECT
lamronbAlamroN
Normal
Abnormal
Coronary 
    CTA
Hybrid (coronary CTA/SPECT):
Normal
1-CVD or 2-CVD 
Hybrid (coronary CTA/SPECT):
Normal
3-CVD or LM 
Hybrid (coronary CTA/SPECT):
Abnormal
Hybrid (coronary CTA/SPECT):
Normal
Hybrid (coronary CTA/SPECT): 
Abnormal
Combinations of (A) CACS, coronary CTA, and SPECT and the related Hybrid (CACS/SPECT)
and (B) Hybrid (coronary CTA/SPECT). CVD ¼ coronary vessel disease; other abbreviations
as in Figure 1.
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556the following manner: no stenosis: 0% diameter
reduction (w0% area reduction); mild stenosis: 1% to
29% diameter reduction (w1% to 50% area reduction);
moderate stenosis: 30% to 49% diameter reduction
(w50% to 69% area reduction); and severe stenosis:
50% to 100% diameter reduction (w70% to 100% area
reduction). Obstructive CAD was deﬁned as a segment
with a diameter >2 mm and a minimum 50% reduc-
tion in luminal diameter (w70% area reduction).
Nonevaluable segments with a diameter >2 mm
were deﬁned as having obstructive CAD. Coronary
CTA scan results were deﬁned as abnormal if
obstructive CAD was not ruled out in all coronary
segments. No patients or segments were excluded
from the analysis.
SPECT ACQUISITION AND INTERPRETATION. Gated
SPECT was acquired by using a dedicated gamma
camera (CardioMD, Philips Healthcare, Best, the
Netherlands). Studies were performed by using a 1-day
stress study protocol. If needed for image interpreta-
tion, a rest study was performed on a separate
day. Myocardial stress was induced by adenosine
(140 mg/kg) during low-level bicycle ergometer exer-
cise or, in patients with chronic obstructive pulmonary
disease, according to bicycle ergometer alone or byusing dobutamine. 99mTc-sestamibi was used in both
stress (500 MBq) and rest (700 MBq) studies. All
images were automatically analyzed without attenu-
ation correction by using commercially available soft-
ware (QGS/QPS, Cedars-Sinai, Los Angeles, California).
Subsequent images were visually corrected and
interpreted.
SPECT images were assessed by using a 17-segment
model. All segments were scored for perfusion de-
fects by using a 5-point scoring system (0: normal; 4:
absence of tracer uptake). An abnormal SPECT due to
a reversible myocardial perfusion defect was deﬁned
as a summed difference score $4. In addition, a
reduction of left ventricular ejection fraction of >10%
during stress or a transient ischemic dilation value of
>1.22 was deﬁned as abnormal. For patients with
no previous coronary revascularization, an irrevers-
ible perfusion defect or left ventricular ejection fra-
ction <45% was considered abnormal.
HYBRID IMAGING INTERPRETATION. According to
the pre-deﬁned protocol, CACS, coronary CTA, and
SPECT results were interpreted separately as normal
or abnormal. Subsequently, the results were com-
bined to give an integrated hybrid imaging result.
The Hybrid (CACS/SPECT) was categorized as
normal when CACS was <400 or CACS was >400 and
SPECT was normal. Hybrid (CACS/SPECT) was cate-
gorized as abnormal when CACS was >400 and SPECT
was abnormal (Figure 2A). The Hybrid (coronary CTA/
SPECT) result was categorized as normal when both
coronary CTA and SPECT results were normal, coro-
nary CTA was normal, and the SPECT was abnormal or
coronary CTA was abnormal with 1-vessel or 2-vessel
disease and the SPECT was normal. The Hybrid
(coronary CTA/SPECT) result was categorized as
abnormal when coronary CTA was abnormal with
3-vessel disease and the SPECT was normal or both
coronary CTA and SPECT results were abnormal
(Figure 2B).
ICA ACQUISITION AND INTERPRETATION. ICA was
performed by using the contrast medium iodixanol
(350 mg/ml) and standard techniques including intra-
coronary glyceryl nitrate (200 mg). When a coronary
stenosis was visually estimated to be greater than a
30% luminal diameter stenosis in a coronary segment
with a luminal diameter >2 mm, a quantitative coro-
nary angiography analysis was performed. Dedicated
quantitative coronary angiography software (QAn-
gioXA 7.3, Medis, Leiden, the Netherlands) was used
for the analysis. Image frames of the coronary stenosis
were selected in the end-diastolic phase with a mini-
mal overlapping of vessels. Obstructive CAD was
deﬁned as a minimum 50% reduction in luminal
TABLE 1 Patient Demographic Characteristics (N ¼ 138)
White 128 (92.8)
Male 94 (68.1)
Age, yrs 54 (22–72)
Body mass index, kg/m2 25.8  4.3
Kidney diagnosis and status
Etiology of kidney failure
Diabetes 38 (27.5)
Hypertension or glomerulosclerosis 36 (26.1)
Glomerulonephritis or connective tissue disease 31 (22.5)
Polycystic kidney disease 17 (12.3)
Other diagnosis 16 (11.6)
Chronic kidney disease stage 5, nondialysis 79 (57.2)
Estimated glomerular ﬁltration rate, ml/min/1.73 m2 12.7  5.9
Chronic kidney disease stage 5, dialysis 59 (42.8)
Peritoneal dialysis 18
Hemodialysis 41
Treatment with dialysis, months 36.9 (1–204)
Previous kidney transplantation 23 (16.7)
Cardiovascular risk factors and disease
Diabetes 46 (33.3)
Hypertension 129 (93.5)
Dyslipidemia 69 (50.0)
Smoking, active 43 (31.2)
Established cardiovascular disease 19 (13.8)
Previous percutaneous coronary intervention 8 (5.8)
Values are n (%), mean (range), or mean  SD. Hypertension was noted if the patient received
antihypertensive medical treatment; dyslipidemia if the patient received statin treatment or total
cholesterol was >6.2 mmol/l (240 mg/dl); established cardiovascular disease comprised previous
myocardial infarction, stroke, transitory cerebral ischemia, peripheral artery disease, or veriﬁed
intermittent claudication.
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557diameter (w70% area reduction) according to quanti-
tative coronary angiography.
SAMPLE SIZE CALCULATION. Derived from historical
data, a coronary stenosis prevalence of 30%, a sensi-
tivity of 0.88, and a speciﬁcity of 0.75 for both coronary
CTA and SPECT were assumed. On the basis of these
assumptions, a ﬁnal study cohort of 135 patients was
required for a minimum of 10% absolute precision on
either side (one-half the width of the 95% CI) of the
expected sensitivity and speciﬁcity. With an expected
dropout rate of 10%, a minimum of 150 patients
was needed to achieve sufﬁcient power of the study.
STATISTICAL ANALYSIS. Continuous variables were
expressed as mean or median  SD, total or inter-
quartile range, or percentiles. Categorical variables
were reported as frequencies (percentages). Sensi-
tivity, speciﬁcity, positive and negative predictive
values (PPV and NPV, respectively), and positive and
negative likelihood ratios (PLR and NLR) were calcu-
lated for the noninvasive diagnostic tests, with
quantitative ICA as reference. McNemar’s test was
used to compare sensitivity and speciﬁcity. The
kappa coefﬁcient was calculated to measure the de-
gree of nonrandom agreement between readers’
diagnostic conclusions. For all statistical analysis, a
2-tailed p value <0.05 was considered statistically
signiﬁcant, and 95% CIs were reported when appro-
priate. Statistical analysis was performed using Stata
version 13 (Stata Corp., College Station, Texas).
RESULTS
A total of 167 patients were studied. Twenty-nine
patients were excluded because they did not com-
plete the coronary CTA, SPECT, or ICA, leaving a ﬁnal
cohort of 138 patients (Figure 1). Baseline character-
istics are summarized in Table 1. Only 4 patients had
typical symptoms of exercise-induced angina pecto-
ris. The median intertest interval from ﬁrst nonin-
vasive test to the ICA was 34 days (10th and 90th
percentiles: 24 and 48 days).
INVASIVE CORONARY ANGIOGRAPHY. Thirty pa-
tients (22%) had obstructive CAD on quantitative
coronary angiography. One-vessel disease was pre-
sent in 22 (16%) patients, 2-vessel disease in 5 (4%)
patients, and 3-vessel or left main artery disease in 3
(2%) patients (Table 2). Twenty patients had stenosis
in a proximal coronary segment.
CORONARY ARTERY CALCIUM SCORE. The median
Agatston CACS was 137 (interquartile range: 0 to 570).
The CACS was 0 in 35 (25%) patients and >400 in 45
(33%) patients (Table 2). The prevalence of obstructive
CAD was 0% and 44% in patients with CACS of 0 and>400, respectively. With a CACS threshold of 400, the
sensitivity, speciﬁcity, PPV, and NPV for the detection
of obstructive CAD deﬁned according to ICA were 67%
(95% CI: 47% to 83%), 77% (95% CI: 68% to 84%), 44%
(95% CI: 30% to 60%), and 89% (95% CI: 81% to 95%),
respectively, in a patient-level model (Figures 3A
and 4). The PLR and NLR were 2.9 (95% CI: 1.9 to 4.4)
and 0.4 (95% CI: 0.3 to 0.7). The sensitivity for
obstructive CAD in a proximal segment was 70% (95%
CI: 46% to 88%).
CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY.
The mean number of segments analysis at coronary
CTA was per patient 11.5  2.4. The mean number of
segments <2 mm was 2.5  1.4, and not anatomically
present was 3.4  1.3 segments. The mean number of
nonanalyzable segments per patient due to reduced
contrast was 0.1  0.4, movement artifact was 0.3 
1.0, and other reason was 0.2  0.9; a total of 25 pa-
tients were affected. During coronary CTA acquisi-
tion, the mean heart rate was 67  11 beats/min.
Sixty-eight patients (49%) had an abnormal coro-
nary CTA scan. Two patients were misclassiﬁed as
normal according to coronary CTA despite obstructive
CAD on ICA. Stenoses in these 2 patients were located
TABLE 2 Imaging Study Characteristics (N ¼ 138)
Invasive coronary angiography
Obstructive coronary artery disease 30 (21.7)
1-vessel disease 22 (15.9)
2-vessel disease 5 (3.6)
3-vessel or left main artery disease 3 (2.2)
CACS 137 (0–570)
0 35 (25.4)
>0 and #400 58 (42.0)
>400 45 (32.6)
Coronary CTA
Abnormal test result 68 (49.3)
1-vessel disease 21 (15.2)
2-vessel disease 23 (16.7)
3-vessel disease or left main disease 24 (17.4)
SPECT
Abnormal test result 36 (26.1)
Sum difference score $4* 8 (5.8)
Reduction of ejection fraction of >10% during stress* 1 (0.7)
Transient ischemic dilation ratio $1.22* 6 (4.3)
Irreversible defect and/or ejection fraction <45%* 27 (19.6)
Inconclusive images* 1 (0.7)
Hybrid (CACS/SPECT)
Abnormal test result 13 (9.4)
Hybrid (coronary CTA/SPECT)
Abnormal test result 35 (25.4)
Values are n (%), median (interquartile range), or mean  SD. *More than 1 pathologic ﬁnding was
present in 6 patients.
CACS ¼ coronary artery calcium score; CTA ¼ computed tomography angiography;
SPECT ¼ single-photon emission computed tomography.
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558in the distal right coronary artery and in the second
diagonal branch (Figure 3B). The kappa value for the
interobserver variability for coronary CTA was 0.71
(95% CI: 0.59 to 0.83).
The sensitivity, speciﬁcity, PPV, and NPV for diag-
nosing obstructive CAD were 93% (95% CI: 78% to
99%), 63% (95% CI: 53% to 72%), 41% (95% CI: 29 to 54),
and 97% (95% CI: 90 to 100), respectively (Figure 4).
The sensitivity of coronary CTA was higher (p < 0.01)
and speciﬁcity was lower (p < 0.001) compared with
CACS. The PLR and NLR were 2.5 (95% CI: 1.9 to 3.3)
and 0.1 (95% CI: 0.0 to 0.4). The sensitivity for
obstructive CAD in a proximal segment was 100%
(95% CI: 83 to 100).
SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY.
Myocardial stress was induced by adenosine in 127
(92%) patients, dobutamine in 3 (2%), and bicycle
ergometer testing in 8 (6%). A total of 36 (26%) pa-
tients had an abnormal SPECT (Table 2). The kappa
value for interobserver variability according to SPECT
was 0.72 (95% CI: 0.59 to 0.85).
The sensitivity, speciﬁcity, PPV, and NPV were 53%
(95% CI: 34% to 72%), 82% (95% CI: 73% to 88%), 44%
(95% CI: 28% to 62%), and 86% (95% CI: 78% to 92%),
respectively. Comparing the diagnostic performanceof SPECT versus CACS revealed no signiﬁcant differ-
ences. Compared with coronary CTA, the sensitivity
was lower (p < 0.01) and speciﬁcity was higher (p <
0.01) (Figures 3C and 4). PLR and NLR for SPECT were
2.9 (95% CI: 1.7 to 4.8) and 0.6 (95% CI: 0.4 to 0.8).
SPECT sensitivity for obstructive CAD in a proximal
segment increased to 60% (95% CI: 36 to 81) compared
with 53% (95% CI: 34 to 72) in the patient-level model.
HYBRID IMAGING. With the Hybrid (CACS/SPECT)
modality, only 13 (9.4%) patients were categorized as
abnormal according to the CACS threshold of 400.
The sensitivity, speciﬁcity, PPV, and NPV were 33%
(95% CI: 17% to 53%), 97% (95% CI: 92% to 99%), 77%
(95% CI: 46% to 95%), and 84% (95% CI: 76% to 90%),
respectively (Figures 3D and 4). The PLR and NLR
were 12.0 (95% CI: 3.5 to 40.8) and 0.7 (95% CI: 0.6 to
0.7). Sensitivity was signiﬁcantly lower but speciﬁcity
was signiﬁcantly higher compared with CACS, coro-
nary CTA, and SPECT. PPV was higher compared
with any other modality. The sensitivity for obstruc-
tive CAD in a proximal segment was 40% (95% CI:
19% to 64%). If the CACS threshold for a hybrid im-
aging approach had been 0, the sensitivity was equal
to SPECT (p ¼ 1.00) alone, and the speciﬁcity
increased from 82 for SPECT alone to 86% (p ¼ 0.06).
The Hybrid (coronary CTA/SPECT) was categorized
as normal in 70 patients because of a normal coronary
CTA, and the Hybrid (coronary CTA/SPECT) was ab-
normal in 24 patients due to a coronary CTA display-
ing 3-vessel or left main disease. In the 44 patients
with 1- or 2-vessel disease, the Hybrid (coronary CTA/
SPECT) was categorized as normal in 33 patients
because of a normal SPECT, and the Hybrid (coronary
CTA/SPECT) was abnormal in 11 patients due to an
abnormal SPECT. In total, 35 patients were classiﬁed
as abnormal and 103 as normal on the basis of Hybrid
(coronary CTA/SPECT) (Table 2, Figure 2).
The sensitivity, speciﬁcity, PPV, and NPV were 67%
(95% CI: 47% to 83%), 86% (95% CI: 78% to 92%), 57%
(95% CI: 39% to 74%), and 90% (95% CI: 83% to 95%),
respectively, in a patient-level model (Figures 3E
and 4). The PLR and NLR were 4.8 (95% CI: 2.8 to 8.2)
and 0.4 (95% CI: 0.2 to 0.6).
Sensitivity was equal, but speciﬁcity was signiﬁ-
cantly higher with Hybrid (CACS/SPECT) compared
with CACS. Compared with coronary CTA, the sensi-
tivity was signiﬁcantly lower, whereas speciﬁcity was
signiﬁcantly higher. Moreover, the sensitivity and
speciﬁcity of Hybrid (coronary CTA/SPECT) were
nonsigniﬁcantly higher than SPECT. PPV increased
from 41% for coronary CTA and 44% for SPECT to 57%
for the combined Hybrid (coronary CTA/SPECT).
For proximal segments, the sensitivity for Hybrid
(coronary CTA/SPECT) was 75% (95% CI: 51% to 91%).
FIGURE 3 Cross-Tabulation of Noninvasive Test Results Versus the ICA
A CACS
< 400 ≥ 400
Normal
Abnormal
ICA
83 (60.1%)
10 (7.2%)
25 (18.1%)
20 (14.5%)
B Coronary CTA
Normal Abnormal
Normal
Abnormal
ICA
68 (49.3%)
2 (1.4%)
40 (29.0%)
28 (20.3%)
C SPECT
Normal Abnormal
Normal
Abnormal
ICA
88 (63.8%)
14 (10.1%)
20 (14.5%)
16 (11.6%)
D Hybrid (CACS/SPECT)
Normal Abnormal
Normal
Abnormal
ICA
105 (76.1%)
20 (14.5%)
3 (2.2%)
10 (7.2%)
E Hybrid (Coronary CTA/SPECT)
Normal Abnormal
Normal
Abnormal
ICA
93 (67.4%)
10 (7.2%)
15 (10.9%)
20 (14.5%)
Cross-tabulation of CACS (A), SPECT (B), coronary CTA (C), Hybrid (CACS/SPECT) (D), and Hybrid (coronary CTA/SPECT) (E) results versus the ICA. Values
are n (%). N ¼ 138. Abbreviations as in Figure 1.
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559FOLLOW-UP AND SAFETY. Acute renal failure. A
total of 95 ml of contrast medium was used for the
CTA of the coronary arteries, aorta, and iliac arteries.
For ICA, the mean contrast dose of medium was 52 
22 ml. Seven (9%) of the 79 patients included were not
on dialysis at inclusion but began dialysis treatment
in the time interval between the coronary CTA and
the ICA. In addition, 4 (6%) patients began dialysis
treatment within 30 days after the ICA. In all cases,
dialysis treatment was planned and was not consid-
ered to be due to contrast-induced nephropathy.
Complications. During the 30-day follow-up, 8 patients
needed additional hospital observation for groin
hematomas after the femoral access ICA. No major
vascular or other complications were registered.
DISCUSSION
The main ﬁnding in this study was that coronary CTA
had a signiﬁcantly higher sensitivity and NPV for
diagnosing obstructive CAD but a lower speciﬁcitythan CACS and SPECT. Hybrid imaging with coronary
CTA and SPECT had a moderate sensitivity and a high
speciﬁcity compared with SPECT or coronary CTA
alone.
CACS AND CORONARY CTA. The pre-deﬁned CACS
threshold of 400 in this study had moderate diag-
nostic accuracy, equal to SPECT. This result is similar
to that of Rosario et al. (9), who investigated the best
CACS threshold for predicting obstructive CAD in
97 kidney transplantation candidates. The optimal
CACS cutoff in this study was 187, yielding a sensi-
tivity and speciﬁcity of 65% and 66%.
The applicability of coronary CTA before kidney
transplantation was studied by Mao et al. (10). Of the
29 study patients with CKD-5 undergoing dialysis, 36%
had normal coronary arteries with a CACS of zero. The
authors excluded obstructive CAD in 70% of the cohort
by using coronary CTA. The accuracy of coronary CTA
was not compared with ICA in their study but was in
2 subsequent studies. Jug et al. (11) examined 31
FIGURE 4 Diagnostic Performance
100
90
80
70
60
50
40
30
20
10
0
Pe
rc
en
t (
%)
Sensitivity
CACS 
Coronary CTA 
SPECT 
CACS/SPECT 33 97 77 84
Coronary 
CTA/SPECT 
67 77 44 89
93 63 41 97
53 82 44 86
67 86 57 90 
Specificity PPV NPV
CACS, SPECT, coronary CTA, Hybrid (CACS/SPECT), and Hybrid (coronary CTA/SPECT) compared with ICA. N ¼ 138. Error bars represent
95% conﬁdence intervals. NPV ¼ negative predictive value; PPV ¼ positive predictive value; other abbreviations as in Figure 1.
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560patients with advanced CKD referred for coronary CTA
and ICA as part of a pre-transplantation clinical eval-
uation or as part of the ACCURACY (Assessment by
Coronary Computed Tomographic Angiography of In-
dividuals Undergoing Invasive Coronary Angiog-
raphy) trial (5). The median CACS was 519, and the
prevalence of ICA-veriﬁed obstructive CAD was high
(61%). Coronary CTA had a sensitivity and speciﬁcity
of 100% and 91%, respectively. Park et al. (12) evalu-
ated 87 patients with CKD-5 undergoing dialysis by
using coronary CTA as part of the clinical evaluation or
the evaluation before kidney transplantation. The
median CACS was 138. ICA was performed in 29 (33%)
patients, and 14 (48%) had obstructive CAD. Sensi-
tivity and speciﬁcity were of the same order of
magnitude as in the study by Jug et al. (11).
Our study is the ﬁrst to prospectively compare the
diagnostic performance of coronary CTA in a large
cohort with advanced CKD without selection bias and
partial veriﬁcation bias. The high sensitivity of coro-
nary CTA in our study is in line with the 2 previous
studies of patients with advanced CKD and in studies
in the general population. The reduced speciﬁcity
compared with previous studies of patients with CKD
is related to a high rate of false-positive coronary CTA
results, most likely due to a high calcium burden in
coronary vessels without obstructive CAD. This type
of patient might have been more frequent in our
cohort of predominantly asymptomatic CKD patients.The high prognostic value of coronary CTA in the
general population has been conﬁrmed in patients
with advanced CKD (13–15). De Bie et al. (14) showed
that in patients with CKD-5 undergoing dialysis and
obstructive CAD at coronary CTA, the incidence of
cardiovascular events after 2 years of follow-up was
36% versus 0% in patients without stenosis.
SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY.
In a recent Cochrane review of kidney transplantation
candidates, results from 7 small SPECT studies were
merged and a reference threshold of $70% luminal
cross-sectional area stenosis by ICA was applied as a
cutoff value for obstructive CAD (3). The pooled
sensitivity was 0.67 (95% CI: 0.48 to 0.82) and the
speciﬁcity was 0.77 (95% CI: 0.61 to 0.88), consistent
with the diagnostic performance of SPECT in the
present study.
The reduced diagnostic performance of SPECT in
patients with advanced CKD compared with the
general population may be due to an impaired
response to myocardial stress agents (16,17). In addi-
tion, false-negative results may be obtained in pa-
tients with severe CAD and balanced ischemia.
Finally, SPECT requires a substantial area of ischemia
(10% of the myocardium) to be determined as posi-
tive, and it might not identify coronary stenosis in
vessels supplying smaller territories. However, in
our study, the sensitivity of SPECT was not substan-
tially increased when only proximal stenosis was
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561considered. Nonetheless, SPECT may still provide
additional prognostic information in kidney trans-
plantation candidates (2).
HYBRID IMAGING. Although anatomic detection of
atherosclerosis and functional detection of ischemia
might provide better diagnostic accuracy and short-
and long-term risk assessment (8,18), no previous
study has quantiﬁed the diagnostic accuracy or
prognostic value of a noninvasive hybrid imaging
approach in patients with CKD.
Hybrid (CACS/SPECT) with a CACS threshold of 400
had reduced sensitivity compared with the other
modalities. However, a high PPV was achieved in the
13 patients with an abnormal test result. There was a
minimal beneﬁt of a hybrid imaging approach, with a
CACS threshold of 0 compared with SPECT alone.
Previous studies in the general population used
different methods to merge coronary CTA and SPECT
into a Hybrid (coronary CTA/SPECT) result. A
consensus regarding the methods has not been ach-
ieved. Schaap et al. (8) conducted a hybrid imaging
study in which coronary CTA and SPECT were sepa-
rately categorized as normal, nonconclusive, or
abnormal and subsequently merged into a hybrid
result. Compared with ICA and fractional ﬂow
reserve, the diagnostic accuracy of hybrid imaging
demonstrated sensitivity, speciﬁcity, PPV, and NPV
as high as 96%, 95%, 96%, and 95%, respectively.
In the present study, a simple and clinically appli-
cable method was used to merge coronary CTA and
SPECT into a Hybrid (coronary CTA/SPECT) result.
The rationale was that the Hybrid (coronary CTA/
SPECT) was classiﬁed as normal regardless of the
SPECT result when the coronary CTA results were
normal because of the very high NPV of coronary CTA.
In addition, it was classiﬁed as abnormal regardless
of the SPECT result when the coronary CTA displayed
3-vessel or left main disease because of the risk of
“balance ischemic” vessel disease, a situation in which
the SPECT result is false negative due to the ﬂow
reserve of each of the coronary arteries being equally
impaired. The Hybrid (coronary CTA/SPECT) reduced
the sensitivity and increased the speciﬁcity compared
with coronary CTA alone, and the PPV increased from
41% for coronary CTA to 57% for the Hybrid (coronary
CTA/SPECT). Hybrid (coronary CTA/SPECT) out-
performed SPECT on all diagnostic variables.
CLINICAL IMPLICATIONS. To date, only 1 randomized
study has evaluated the beneﬁt of coronary revascu-
larization compared with medical treatment before
kidney transplantation (19). The study included pa-
tients with diabetes and was terminated prematurely
due to a high number of events in the nonrevas-
cularized study arm. However, data justifying a beneﬁtof general cardiac evaluation before kidney trans-
plantation are not available and might be difﬁcult to
achieve with the low sensitivity of the myocardial
perfusion imaging techniques used in previous stra-
tegies. With a more exact diagnosis of CAD, it may be
possible to optimize individualized medical treatment
(e.g., statin, aspirin, beta-blockade therapy). In addi-
tion, careful perioperative management and coronary
revascularization might also reduce morbidity and
mortality.
We demonstrated that coronary CTA can be used
with high sensitivity and NPV to diagnose coronary
stenosis during cardiac evaluation of kidney trans-
plantation candidates. However, the high number of
false-positive results indicates that additional down-
stream testing is necessary in some patients. The low
sensitivity of SPECT means that this method must be
removed from the ﬁrst-choice modality for diag-
nosing obstructive CAD in potential kidney transplant
patients. Cardiac magnetic resonance imaging is not
feasible due to the contraindication of gadolinium in
patients with advanced CKD. The hybrid imaging
approach with SPECT as a secondary stress test after
coronary CTA may be used to reduce the need for ICA
but at the cost of lower sensitivity.
Our study may provide an alternative to current
guidelines that recommend stress testing as the
initial approach to rule out coronary stenosis in kid-
ney transplant candidates. Initial coronary CTA can
identify these patients without further diagnostic
testing and reduce the need for subsequent stress
imaging testing or ICA.
STUDY LIMITATIONS. We used the clinical standard
for addressing obstructive CAD on coronary CTA, 50%
diameter stenosis visual assessment, and compared
this with a 50% diameter stenosis assessment using
quantitative analysis of ICA. A visual assessment of
stenosis at coronary CTA was used, which may over-
estimate stenosis compared with quantitative assess-
ment (20–22). We also compared a coronary anatomic
test (coronary CTA) and a myocardial ischemia test
(SPECT) with ICA as reference. ICA is a coronary
anatomic test, and angiographically obstructive CAD
may not always cause myocardial ischemia. This
method may have limited the diagnostic accuracy of
SPECT and hybrid imaging and favored coronary CTA.
CONCLUSIONS
Coronary CTA is a safe, feasible, and reliable test for
ruling out obstructive CAD in kidney transplantation
candidates. Compared with SPECT, coronary CTA had
higher sensitivity but lower speciﬁcity. Coronary CTA
seems to be a valid alternative to an initial diagnostic
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE:
Cardiac risk stratiﬁcation of kidney transplantation
candidates is important due to a high incidence of
cardiovascular disease in patients with end-stage renal
disease. Due to the relatively low accuracy of nonin-
vasive stress testing in this population, alternative
methods should be considered. Coronary CTA has
emerged as a noninvasive alternative to stress testing
for the diagnosis of CAD.
TRANSLATIONAL OUTLOOK: Future large-scale
prospective comparative effectiveness studies are
required to determine the most clinically and cost-
efﬁcient approach to evaluation of patients considered
for renal transplantation.
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562strategy using a stress imaging test and invasive
angiography. A hybrid imaging approach with coro-
nary CTA and SPECT did not improve overall diag-
nostic accuracy compared with coronary CTA alone.
However, the PPV was increased by using hybrid im-
aging that advocated personalized downstream
testing including either SPECT or ICA after an initial
diagnostic strategy with coronary CTA in pa-
tients undergoing cardiac evaluation before kidney
transplantation.
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